AllianceBernstein’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-558,777
| Closed | -$15.7M | – | 3473 |
|
|
2022
Q1 | $15.7M | Buy |
558,777
+40,099
| +8% | +$1.1M | 0.01% | 1021 |
|
|
2021
Q4 | $14.2M | Buy |
518,678
+11,240
| +2% | +$305K | 0.01% | 1083 |
|
|
2021
Q3 | $13.8M | Buy |
507,438
+468,238
| +1,194% | +$11.6M | 0.01% | 1081 |
|
|
2021
Q2 | $670K | Hold |
39,200
| – | – | ﹤0.01% | 2691 |
|
|
2021
Q1 | $818K | Hold |
39,200
| – | – | ﹤0.01% | 2484 |
|
|
2020
Q4 | $898K | Sell |
39,200
-2,200
| -5% | -$41.9K | ﹤0.01% | 2341 |
|
|
2020
Q3 | $675K | Sell |
41,400
-1,100
| -3% | -$19.9K | ﹤0.01% | 2370 |
|
|
2020
Q2 | $575K | Buy |
42,500
+11,200
| +36% | +$130K | ﹤0.01% | 2516 |
|
|
2020
Q1 | $371K | Buy |
31,300
+1,700
| +6% | +$37.7K | ﹤0.01% | 2503 |
|
|
2019
Q4 | $737K | Hold |
29,600
| – | – | ﹤0.01% | 2403 |
|
|
2019
Q3 | $503K | Hold |
29,600
| – | – | ﹤0.01% | 2543 |
|
|
2019
Q2 | $674K | Sell |
29,600
-1,100,302
| -97% | -$29.7M | ﹤0.01% | 2478 |
|
|
2019
Q1 | $36.3M | Buy |
1,129,902
+37,966
| +3% | +$1.17M | 0.02% | 626 |
|
|
2018
Q4 | $30.8M | Sell |
1,091,936
-10,513
| -1% | -$308K | 0.02% | 626 |
|
|
2018
Q3 | $31.7M | Sell |
1,102,449
-346,672
| -24% | -$10.4M | 0.02% | 654 |
|
|
2018
Q2 | $54.3M | Sell |
1,449,121
-45,202
| -3% | -$1.77M | 0.04% | 478 |
|
|
2018
Q1 | $58.7M | Buy |
1,494,323
+27,593
| +2% | +$1.01M | 0.04% | 442 |
|
|
2017
Q4 | $47.5M | Buy |
1,466,730
+161,723
| +12% | +$4.85M | 0.03% | 504 |
|
|
2017
Q3 | $40.7M | Buy |
1,305,007
+373,502
| +40% | +$11.1M | 0.03% | 542 |
|
|
2017
Q2 | $26M | Buy |
931,505
+898,785
| +2,747% | +$20.3M | 0.02% | 670 |
|
|
2017
Q1 | $561K | Hold |
32,720
| – | – | ﹤0.01% | 2492 |
|
|
2016
Q4 | $396K | Sell |
32,720
-4,900
| -13% | -$63.4K | ﹤0.01% | 2637 |
|
|
2016
Q3 | $596K | Hold |
37,620
| – | – | ﹤0.01% | 2468 |
|
|
2016
Q2 | $486K | Sell |
37,620
-283,260
| -88% | -$4.43M | ﹤0.01% | 2531 |
|
|
2016
Q1 | $6.1M | Hold |
320,880
| – | – | 0.01% | 977 |
|
|
2015
Q4 | $7.22M | Buy |
320,880
+71,510
| +29% | +$1.41M | 0.01% | 941 |
|
|
2015
Q3 | $5.83M | Buy |
249,370
+118,290
| +90% | +$3.26M | 0.01% | 1005 |
|
|
2015
Q2 | $3.75M | Buy |
131,080
+61,640
| +89% | +$1.62M | ﹤0.01% | 1283 |
|
|
2015
Q1 | $1.79M | Buy |
+69,440
| New | +$1.59M | ﹤0.01% | 1804 |
|
AllianceBernstein's XENT Position: Q2 2022 in Review
AllianceBernstein sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 558,777 shares — an estimated $15.7M sold.
AllianceBernstein first reported a position in XENT in Q1 2015 and held it in 29 quarters. The position peaked at $58.7M in Q1 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- AllianceBernstein reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- AllianceBernstein sold 558,777 Intersect ENT, Inc shares in Q2 2022, an estimated $15.7M.
- AllianceBernstein first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 29 quarters.
- AllianceBernstein's Intersect ENT, Inc position peaked at $58.7M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.